Open App
Company / Named in our posts

23andMe.

Follow 23andMe

23andMe is a genetics-led consumer healthcare and biotechnology company empowering a healthier future.[1]

01Deal
01

Deals on Carrywatch

Every deal that names 23andMe, and its role in each.

Regeneron Pharmaceuticals, Inc. / 23andMe

Regeneron Pharmaceuticals, Inc. signed an agreement for 23andMe.

See deal details
02

Deal Web

23andMe and 0 firms it shares a posted deal with, and the path to any other firm.

03

News

Loading headlines.

04

Sources

As of 25 Oct 2026.

  1. 01
    Regeneron, A Leading U.S. Biotechnology Company, to Acquire 23andMe in Court-Supervised Sale

    U.S. Securities and Exchange Commission · Researched 25 Oct 2026

  2. 02
    Form 8-K

    U.S. Securities and Exchange Commission · Researched 25 Oct 2026

Deal posts naming 23andMe:

  1. P01